Physician profile
Paul M Simic
NPI 1205867488
$709.67
in general payments reported to CMS, 2019-2025
12 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $13.95 · 2021: $225 · 2024: $65.03 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $270.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $269.63 | 2019-2025 | Quickanchor Orthocord, Dynacord |
| Micromed INC | $135.88 | 2021 | |
| Stryker Corporation | $72.64 | 2025 | Variax |
| Fidia Pharma USA INC. | $44.84 | 2019 | |
| Smith+Nephew, INC. | $31.40 | 2025 | Intellio Link Werewolf, Double Pump Rf |
| Nalu Medical, INC. | $30.61 | 2025 | Nalu Neurostimulation System |
| Amgen INC. | $29.08 | 2025 | Evenity |
| Bioventus LLC | $25.37 | 2019 | |
| Linvatec Corporation | $23.79 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $18.73 | 2024 | Exparel, Iovera, Zilretta |
| Dynasplint Systems INC. | $14.77 | 2019 | |
| Innovation Technologies INC | $12.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Simic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.